I have dedicated my career to understanding the biological, molecular, and genetic underpinnings of human cancer, with a specialty in breast cancer and a focus on prevention. My research is centered on uncovering the root causes of breast cancer and identifying strategies to mitigate risk through prevention-focused approaches.In parallel, I have experience in the development and commercialization of best-in-class diagnostics for the early detection of cancer. My expertise spans biomarker discovery, clinical study design, and the successful execution of diagnostics strategies. I have also led innovative product pipelines, high-throughput operations, and navigated the complexities of reimbursement and regulatory pathways to bring advanced diagnostic tools to market.